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Background: Plants are traditionally used for medicinal treatment of numerous human disorders including infectious
diseases caused by microorganisms. Due to the increasing resistance of many pathogens to commonly used
antimicrobial agents, there is an urgent need for novel antimicrobial compounds. Plants of the genus Rhododendron
belong to the woody representatives of the family Ericaceae, which are typically used in a range of ethno-medical
applications. There are more than one thousand Rhododendron species worldwide. The Rhododendron-Park
Bremen grows plants representing approximately 600 of the known Rhododendron species, and thus enables
research involving almost two thirds of all known Rhododendron species.
Methods: Twenty-six bacterial species representing different taxonomic clades have been used to study the
antimicrobial potential of Rhododendron leaf extracts. Agar diffusion assay were conducted using 80% methanol
crude extracts derived from 120 Rhododendron species. Data were analyzed using principal component analysis
and the plant-borne antibacterial activities grouped according the first and second principal components.
Results: The leaf extracts of 17 Rhododendron species exhibited significant growth-inhibiting activities against
Gram-positive bacteria. In contrast, only very few of the leaf extracts affected the growth of Gram-negative bacteria. All
leaf extracts with antimicrobial bioactivity were extracted from representatives of the subgenus Rhododendron, with 15
from the sub-section Rhododendron and two belonging to the section Pogonanthum. The use of bacterial multidrug
efflux pump mutants revealed remarkable differences in the susceptibility towards Rhododendron leaf extract treatment.
Conclusions: For the first time, our comprehensive study demonstrated that compounds with antimicrobial activities
accumulate in the leaves of certain Rhododendron species, which mainly belong to a particular subgenus. The results
suggested that common genetic traits are responsible for the production of bioactive secondary metabolite(s) which
act primarily on Gram-positive organisms, and which may affect Gram-negative bacteria in dependence of the activity
of multidrug efflux pumps in their cell envelope.
Keywords: Rhododendron, Antimicrobial activity, Gram-positive bacteria, Multidrug efflux pumpBackground
For a long time, medicinal plants have been used as
traditional treatments of a variety of human diseases. In
many parts of the World, different kinds of plant material
are still in use as a major source of traditional medicine
formulations [1-3]. According to the World Health
Organization, approximately 65% of the World’s populations* Correspondence: m.ullrich@jacobs-university.de
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unless otherwise stated.integrate medicinal plants and products generated thereof
into their primary health care strategies [4,5]. Importantly,
in developing countries about 80% of the population is
used to prepare traditional medicine formulation from
plant sources [6].
Bacterial pathogens have developed different types of
resistance to antimicrobial agents, thereby causing a sig-
nificant increase in the costs of diagnostics and pharma-
ceutical treatments. Moreover, resistant microorganisms
contribute to the currently observed dramatic incre-
ments in mortality and morbidity of patients affected byis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for a longer time period due to persisting microbial
infection, the person-to-person transmission rates are
prolonged and thus, enhanced. Increase in morbidity
caused by antibiotics-resistant bacteria was recorded
in several recent out-breaks such as pneumococcal
infections, typhoid fever, and shigellosis in different
regions world-wide [8]. The increasing resistance of
human pathogens to commonly used antimicrobial
agents motivated a renewed interest in the discovery
of novel antimicrobial compounds. Several secondary
metabolites of plants proved effective as biologically
active agents against pathogens [9-11]. This is ex-
plained by the notion that plants acquired most of
their secondary metabolite repertoire during evolution
as metabolic byproducts, which then serve as defense
compounds against predators such as insects and other
herbivores, or against pathogens such as bacteria, fungi,
or viruses [12,13].
Rhododendron L. (Ericaceae) is one of the largest gen-
era of vascular plants and comprises eight subgenera
with more than 1,000 species that populate habitats
mostly in the Northern hemisphere [14]. Extracts of
several species of Rhododendron are used in traditional
medicine in the countries of their indigenous habitats.
Among them are R. ferrugineum L., R. anthopogon Don,
or R. tomentosum (Stokes) Harmaja that are used for the
treatment of inflammation, skin or gastrointestinal tract
disorders, respectively [3,15-18]. These studies showed
that the antibacterial activities of certain species of
Rhododendron could be due to the presence of specific
mono-, di-, or sesquiterpenoids, which had already been
extracted from other plant families [19,20]. However,
there is neither a comprehensive survey of the impressive
number of chemical compounds in this genus nor have
the later been tested systematically for their pharma-
cological potential [21]. The Bremen Rhododendron-Park
possesses an unrivaled diversity of reliably identified
Rhododendron species. Hence, the purpose of the current
study was to comprehensively assess the spectrum of anti-
bacterial activities of extracts prepared from 120 different
Rhododendron species against a broad array of Gram-
positive and Gram-negative bacteria. This study therefore
aims to initiate the further identification and exploitation
of novel plant-borne antibiotics derived from Rhododendron
leaf extracts.
Methods
Plant material and extraction procedure
Fresh leaf material of 120 reliably identified Rhododen-
dron species was collected from plants grown in the
Rhododendron-Park Bremen (www.rhododendronpark
bremen.de) from January 2012 to December 2013. Each
plant species was sampled once without consideringseasonal variations. The identities of all plant species
have been verified according to the German Genebank
Rhododendron Database provided by the Bundessorte-
namt (www.bundessortenamt.de/rhodo) (Additional file 1:
Table S1). Material from all used plant species is publicly
and freely available from the Rhododendron-Park Bremen
upon request. The herein used Rhododendron species
were chosen from five main subgenera: Rhododendron,
Hymenanthes, Tsutsusi, Pentanthera and Azaleastrum, 10
sections, and 34 sub-sections in order to cover a broad
phylogenetic spectrum of plants. Leaf material was
immersed in liquid nitrogen and grinded to powder.
Crude extracts were prepared by re-suspending 2 g
(fresh weight) of leaf powder in 10 mL of the following
solvents: 80% methanol (MeOH), ethyl acetate (EtOAc),
or distilled water, respectively, each for 24 hours at 4°C.
Non-dissolved leaf residues were removed by centrifu-
gation (3,220 × g, 30 min, 4°C). The resulting supernatants
were stored at-20°C, and the remaining, non-extracted
powder was kept at-80°C for long-term storage to ensure
reproducibilty of measurements from a standard reservoir
of plant-derived material.
Bacterial strains
Twenty-six bacterial species were randomly selected
from different taxonomic clades to test for the suscepti-
bility spectrum of crude extracts against a range of
Gram-positive and Gram-negative bacteria (Figure 1).
The phylogenetic tree was constructed by the Neighbor
joining method in the Molecular Evolutionary Genetics
Analysis (MEGA) software version 6 (Tamura, Stecher,
Peterson, Filipski, and Kumar 2013). In order to investi-
gate the role of multidrug efflux systems as bacterial
defense mechanism, wild type and gene-specific mutants
of the following bacterial species were analyzed: Erwinia
amylovora 1189 (wild type), Escherichia coli TG1 (wild
type) [22], Pseudomonas syringae DC3000 (wild type) [23]
as well as the respective mutants with deletions in acrAB,
tolC, or mexAB [24-28]. Additionally, knockout mutants
of E. amylovora and E. coli with deletions in both, acrAB
and tolC [25,27] were subjected to the antimicrobial
analysis.
Antimicrobial susceptibility test
Antimicrobial activity screening was conducted by the
agar diffusion method [29]. Briefly, Lysogeny Broth (LB)
agar plates were inoculated with 200 μL of the inoculum
of the tester organism (1 × 107 colony forming units
per mL) by evenly spreading the cell suspensions
over the agar surface. Holes with diameters of 5 mm
were punched into the agar plates. Subsequently, 50 μL
of the plant crude extracts were filled into each well.
The plates were incubated overnight at 28°C or 37°C,
according to the optimal growth temperature of each
Figure 1 Phylogenetic tree based on bacterial 16S rRNA gene sequences. The phylogenetic tree was constructed using the neighbor-joining
method showing the bacterial organisms (numbers in brackets) used in this study. Bootstrap values (1,000 replicates) lower than 50% are not shown.
▲ Filled triangles indicate the phylogenetic position of human pathogens which have not been used in this study. The scale bar 0.02 indicates 2% of
nucleotide sequence substitution. The strain numbers are indicated in brackets.
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determined by measuring the radius of the inhibition
zone. For each bacterial strain, 80% methanol and 100%
EtOAc solutions were used as negative solvent controls.
All experiments were performed in triplicates and the
results are presented as mean values.
Principal component analysis and data analysis
Principal component analysis (PCA) as multivariate ana-
lysis of data was used to handle the multi-dimensionality
of the data sets and to transform them into new, uncor-
related variables called principal components [30]. One
hundred and twenty Rhododendron samples were tested
against 26 bacterial strains (variables) using a random
cross validation method. The matrix was designed by
using the inhibition zone (mm). PCA was performed
with The Unscrambler® 9.6 (CAMO AS, Oslo, Norway)
software. All graphs were plotted using Origin (OriginLab,
Northampton, MA).
Results
Bioactive metabolites and efficiency of solvent extraction
Initially, Bacillus subtilis 168 and Escherichia coli TG1
were used as model organisms for Gram-positive and
Gram-negative bacteria, respectively. Crude leaf extracts
from 120 Rhododendron species were obtained using
different solvents in order to test for their efficacy to
extract biologically active compounds from the plant
material. The susceptibility of both bacterial model
organisms was tested towards each of the crude leaf
extracts. The antibacterial activity of Rhododendron leaf
extracts obtained with MeOH or EtOAc as solvents was
determined and categorized into three classes according
to the radius of the inhibition zone: a) extracts of
13 Rhododendron species caused no inhibition, b) 71 ex-
tracts caused low inhibition (radius of less than 4 mm),
and c) leaf extracts of 36 Rhododendron species caused
inhibition (radius ranging from 4 to 12 mm) of growth
of either E. coli or B. subtilis (Figure 2). None of the
Rhododendron crude extracts obtained with distilled
water showed any antibacterial activity (data not shown)
indicating that bioactive compounds from Rhododendron
are not readily water-soluble. The used solvent concen-
trations did not impact bacterial growth since treatment
with MeOH and EtOAc alone did not induce inhibition
zones (data not shown). In contrast, MeOH- and EtOAc-
derived leaf extracts exhibited differential effects in that
they were partially significantly active on both model or-
ganisms, suggesting that the contents or the concentration
of potentially bioactive substances in the crude extracts
might vary from one species of Rhododendron to the
other. Interestingly, both tester organisms were generally
more susceptible to treatment with the MeOH extracts
while the EtOAc extracts showed less antimicrobial effects(Figure 2), indicating that methanol was more suitable to
extracting bioactive compound(s) from powdered Rhodo-
dendron leaves. The extent by which the growth of the
tester organisms was inhibited suggested a broad range of
activities, which is possibly explained either by different
compounds in various Rhododendron species or by diverse
mechanisms of inhibition of bacterial growth mediated by
the produced compounds.
Spectrum of microbial susceptibility towards Rhododendron
crude extracts
In order to test a wider spectrum of bacterial organisms,
the antimicrobial activity test with all 120 Rhodo-
dendron crude extracts was extended to a set of 24
additional bacterial tester strains representing both, a
broad phylogenetic spectrum as well as intra-genus
diversity (Figure 1). As observed above, MeOH and
EtOAc as solvents alone had no impact on growth of
any of the tested bacterial organisms (data not shown).
PCA was used to classify the spectrum of bioactivities
of all Rhododendron extracts against all bacterial tester
organisms according to their phylogenetic relatedness
(Figure 3). The first and second principal components
PC1 and PC2 explained 82% of the data indicating
a high robustness of analysis. The data revealed that
the microbial susceptibility towards Rhododendron ex-
tracts can be grouped into one group representing all
Gram-positive tester organisms, while another group
contained 17 out of 18 Gram-negative species (Figure 3)
irrespective of the nature of the Rhododendron extract
applied. The only Gram-negative species showing a
similar susceptibility pattern as Gram-positive or-
ganisms was the alpha-protobacterium Sinorhizobium
meliloti.
Five out of the 120 Rhododendron leaf extracts
showed no growth inhibitory activity against any of the
Gram-positive tester organisms: R. elliottii Watt ex
Brandis, R. hylaeum Balfour & Farrer, R. ponticum L., R.
keiskei Miquel, and R. eriocarpum (Hayata) Nakai (data
not shown). These Rhododendron species belong to the
subgenera Hymenanthes (three species), Rhododendron,
and Tsutsusi, respectively. However, crude extracts ob-
tained from 38 other Rhododendron species exhibited a
moderate antimicrobial activity against 12 out of the 26
tested bacterial species. These plant species belonged
to the subgenera Azaleastrum, Hymenanthes, Rhodo-
dendron, or Tsutsusi. The crude extracts derived from the
remaining 77 Rhododendron species showed significant
bioactivities against at least one of the 26 tester organisms.
It is important to note that the spectrum of microbial sus-
ceptibilities towards Rhododendron extracts varied widely
and showed dramatic differences, i.e. some of the tester
organisms were susceptible towards leaf extracts from
most of the Rhododendron species while other bacterial
Figure 3 PCA score plot. Principal component analysis for score plot (random cross validation method) of the entire dataset (only PC1 vs. PC2
shown). Every dot represents one bacterial species and each color represents a particular group of bacterial organisms.
Figure 2 Antimicrobial activities of methanol- and ethyl acetate-obtained crude leaf extracts of different Rhododendron species against
B. subtilis and E. coli. The radius of the inhibition zones was measured in triplicates and the values are given as means ± standard deviations.
Treatment with solvents were used as negative controls and did not yield in inhibition zones (data not shown).
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Rhododendron leaf extracts. Bacillus thioparus was
the most sensitive tester species susceptible to all 77
potentially bioactive Rhododendron leaf extracts. The
other tested Gram-positive bacteria showed similar
susceptibility only towards leaf extracts derived from
the 17 most bioactive Rhododendron species (Figure 4,
Table 1).
In contrast, susceptibilities of the tested Gram-
negative bacterial strains were classified into either low
or moderate extent. Only one Gram-negative species,
Sinorhizobium meliloti, belonging to the order of alpha-
proteobacteria exhibited susceptibility to most of the
bioactive Rhododendron extracts and was therefore similar
in its susceptibility to the majority of Gram-positive
bacteria (Figure 3, sample no. 19).
On one side, the PCA allowed classification of the
bacterial tester organisms according to their degree of
susceptibility after incubation with Rhododendron ex-
tracts. On the other hand, the analysis performed in this
study allowed to successfully categorized the represen-
tatives of the genus Rhododendron into bioactive and
non-bioactive species (Figure 4), where bioactivity
is understood as antimicrobial activity as assayed by
growth inhibition on LB-agar plates. The results illus-
trated that 41% of all analyzed species of the subgenus
Rhododendron were highly bioactive against the majority
of Gram-positive bacteria tested herein. In contrast, only
two of the 14 species (14%) of the subgenus Pentanthera
showed similarly high antimicrobial bioactivity. The majority
of the remaining Rhododendron species representing other
subgenera exhibited only moderate or low antimicrobial
activities.Figure 4 PCA loading plot. Principal component analysis for loading plot
represents one Rhododendron species and each color represents a subgenuRole of bacterial multidrug efflux pumps as potential
resistance mechanisms
One important observation herein was the finding of
higher susceptibility of Gram-positive over Gram-negative
tester organisms towards Rhododendron leaf extracts,
suggesting an easier passage of potential bioactive com-
pounds into Gram-positive cells. In order to find out,
whether one of the best studied antibiotics resistance
mechanism, the RND-type multidrug efflux pump system
of Gram-negative bacteria, is responsible for the lower
susceptibility of the latter organisms, previously generated
gene-specific knock-out mutants of E. coli, Erwinia amylo-
vora, and Pseudomonas syringae with gene deletions in
the multidrug efflux pump components acrAB, tolC, or
mexAB were analyzed by treating them with crude ex-
tracts of R. ambiguum Hemsley, R. ferrugineum L., or R.
fastigiatum Franchet (Figure 5). The E. coli wild type as
well as all of its multidrug efflux pump mutants exhibited
full resistance to all of the tested leaf extracts. However,
data for the fire blight pathogen, E. amylovora, differed.
While the wild type strain of this bacterium exhibited full
resistance to each one of the tested Rhododendron ex-
tracts, single as well as double mutant strains with dele-
tions of tolC and acrAB exhibited high sensitivity towards
all three tested Rhododendron leaf extracts thereby render-
ing their phenotype to that of the Gram-positive bacteria
(Figure 5). The mexAB multidrug efflux pump mutant of
P. syringae did not show a significant reduction in growth
when exposed to any of the Rhododendron leaf extracts.
In summary, these data suggested that some but not
all of the multidrug efflux pump systems are likely to be
directly involved in export of Rhododendron-derived bio-
active antimicrobial compounds.for 120 Rhododendron species (only PC1 vs. PC2 shown). Every dot
s of Rhododendron.
Table 1 List of Rhododendron species with the highest antimicrobial activities against Gram-positive bacteria
Genebank-no.* Species name Section Sub-section
100.345 R. ferrugineum L. Rhododendron Rhododendron
100.007 R. ambiguum Hemsley Rhododendron Triflora
2006/232 R. anthopogon Don ssp. anthopogon Betty Graham Pogonanthum -
NA R. hirsutum L. Rhododendron Rhododendron
100.906 R. anthopogon ssp. hypenanthum Bale. F. & Cullen Pogonanthum -
100.326 R. concinnum Hemsley Rhododendron Triflora
100.881 R. sichotense Pojarkova Rhododendron Rhodorastra
100.322 R. cinnabarinum Hooker Rhododendron Cinnabarina
NA R. racemosum Franchet Rhododendron Scabrifolia
100.882 R. ledebourii Pojarkova Rhododendron Rhodorastra
100.404 R. rubiginosum Franchet Rhododendron Heliolepida
100.474 R. xanthostephanum Merrill Rhododendron Tephropepla
101.048 R. myrtifolium Schott & Kotschy Rhododendron Rhododendron
100.370 R. minus Michaux Rhododendron Caroliniana
100.392 R. polycladum Franchet Rhododendron Lapponica
100.464 R. spinuliferum Franchet Rhododendron Scabrifolia
100.353 R. hippophaeoides var. hippophaeoides Hutchinson Rhododendron Lapponica
*Gene bank numbers used in the collection of the Rhododendron-Park Bremen.
NA: Not a plant of the German Genebank Rhododendron but a verified plant of the Rhododendron-Park Bremen.
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The purpose of this study was to conduct a comprehen-
sive analysis of antibacterial activities of plants from
the genus Rhododendron, which has the highest species
richness among all woody plant genera [31]. Three
different solvents were compared to optimize extractionFigure 5 Role of the multidrug efflux pump in Gram-negative bacteri
respective RND-type multidrug efflux pump mutants to leaf extracts of thre
wild type. The radius of the inhibition zones was measured in triplicates anefficiency for bioactive compounds from powdered
Rhododendron leaf material. Our results demonstrated
that methanol and ethyl acetate but not water extrac-
tion were suitable for this purpose. This finding is in
agreement with those of previous studies, which re-
ported that most of the bioactive secondary metabolitesa. Susceptibility tests for E. coli, E. amylovora, P. syringae and their
e Rhododendron species effective against Gram-positive bacteria. WT,
d values are given as means ± standard deviations.
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ous methanol extraction [32].
The herein observed susceptibility of Gram-positive
bacteria toward Rhododendron leaf extracts contrasted
the results obtained with the majority of Gram-negative
tester bacteria. This finding might be explained as follows:
The cellular envelopes of either type of bacteria differ dra-
matically and the outer membrane of the Gram-negative
cells with its lipopolysaccharide leaflet might pose an
impermeable barrier for the methanol-extractable Rhodo-
dendron-derived bioactive compounds. Alternatively, various
types of multidrug efflux pumps found in Gram-negative
bacteria might extrude those bioactive compound(s). The
latter hypothesis is strongly supported by findings of this
study in that E. amylovora mutants with defects in
the multidrug efflux pump system AcrAB/TolC were no
longer resistant against treatment with Rhododendron
leaf extracts. Similar conclusions have been drawn pre-
viously by our group with respect to treatment of E.
amylovora with several chemical compounds originating
from other plants [25,33,34]. Interestingly, multidrug ef-
flux pump knock-out mutants of E. amylovora but not
those of E. coli or P. syringae exhibted a significant
growth inhibition when compared to the wild type
strain upon exposure to Rhododendron extracts. These
results indicated that presence of distinct multidrug ef-
flux systems might explain the resistance towards some
of the bioactive Rhododendron extracts. Since neither
E. coli nor P. syringae mutants with the same defects
exhibited growth inhibition upon exposure to these leaf
extracts, additional factors must contribute to the result-
ing resistance in those organisms. This notion points to
an interesting diversity of potential molecular mechanisms
realized in different Gram-negative bacteria, thus provid-
ing some species with resistance towards bioactive com-
pounds extracted from Rhododendron leaves while others
will remain unaffected. In line with this conclusion, it has
been described previously that the permeability of the outer
membrane of E. coli differs from that of other Gram-
negative microorganisms [25]. The diversity of potential re-
sistance mechanisms among Gram-negative bacteria could
also help explaining the unusual high susceptibility of
Sinorhizobium meliloti. A future comparative multi-species
genomic analysis is planned to shed light on the relation-
ship of resistance and expression of individual genes among
different Gram-negative bacterial species.
The herein studied bioactivities of Rhododendron leaf
extracts showed a range of different effects towards the
bacterial tester organisms possibly reflecting the phylo-
gentic diversity of the analyzed Rhododendron species.
The finding agrees with previously published results for
R. anthopogon Don that exhibited antimicrobial activity
against a group of Gram-positive bacteria (e.g. Staphylo-
coccus aureus, Enterococcus faecalis, and Bacillus subtilis)[15]. We hypothesize that different Rhododendron geno-
types may result in the formation of a broad range of com-
pounds due to the diversity in structure and concentration
of secondary metabolites resulting from different meta-
bolic pathways. Previous authors had suggested that this
might explain why certain plants become more or less
susceptible to herbivores [35-37].
In contrast to the studies of others, which demon-
strated that extracts from R. setosum Don, R. ponticum,
R. luteum Sweet, R. arboreum Smith, R. smirnowii
Trautvetter and R. campanulatum Don, inhibited the
growth of E. coli, B. subtilis and S. aureus [18,38-41],
corresponding extracts used in the current study did
not show any antibacterial effects. This discrepancy
might be attributed to a number of factors such as dif-
ferences in compound extractability or in concentra-
tion of the secondary metabolites contained in the
plants depending on the plants’ growing conditions
with respect to variable ranges of biotic (e.g. herbivory,
infection or allelopathy) or abiotic (e.g. nutrient, light,
temperature and drought) stress factors. Some of the
latter had been proven to trigger alterations of the sec-
ondary metabolite composition produced in one and
the same plant species [42-46]. Taken together, we sug-
gest that only a comprehensive and well-controlled
analysis of the antimicrobial compound composition of
plant-derived extracts will allow deciphering of the
underpinning molecular and metabolic pathways, and
only a delineation of genetically related phytomedical
profiling will enable reproducible production of ex-
tracts which might then be useful as precursors for me-
dicinal treatment options.Conclusions
The results obtained in this work revealed that 17
species of the genus Rhododendron exhibited antibac-
terial effects against Gram-positive bacteria. For the
first time, a comprehensive study demonstrated that
there is an accumulation of antimicrobial bioactivities
among Rhododendron species of the subgenus Rho-
dodendron. Consequently, a detailed phylogenetic as-
sessment of the differences of various Rhododendron
subgenera accompanied by in-depth phytochemical
analysis of the extracts might shed light on the actual
nature of the bioactive compound(s). Additionally, a
further analysis of the bacterial susceptibility spectrum
might indicate how the bioactive compound(s) act on
certain microbes. Herein, potential resistance mecha-
nisms of bacteria were shown to differ in a species-
specific manner indicating the necessity to obtain an
array of Rhododendron-derived bioactive compounds
in order to inhibit a broad spectrum of potentially
harmful bacteria.
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